Bill > HR2498

Introduced Session

To amend title XVIII of the Social Security Act to ensure that hospitals receive adequate payment for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes. This bill specifies that payment under Medicare to a hospital for the acquisition costs of an allogeneic hematopoietic stem cell transplant (e.g., bone marrow transplant from a donor) must be made on a reasonable cost basis (similar to the current payment methodology for solid organ acquisitions). The Centers for Medicare & Medicaid Services must determine included items through regulations.

AI Summary

Committee Categories

Ron Kind (D)*,  Pete Aguilar (D),  Gus Bilirakis (R),  Earl Blumenauer (D),  Ted Budd (R),  Ken Calvert (R),  Sean Casten (D),  Judy Chu (D),  Charlie Crist (D),  Peter DeFazio (D),  Theodore Deutch (D),  Tom Emmer (R),  Josh Gottheimer (D),  Richard Hudson (R),  Ro Khanna (D),  John Lewis (D),  Zoe Lofgren (D),  Kenny Marchant (R),  Roger Marshall (R),  Doris Matsui (D),  Tom McClintock (R),  Joe Neguse (D),  Dean Phillips (D),  Harley Rouda (D),  Brad Schneider (D),  Kurt Schrader (D),  Terri Sewell (D),  Jason Smith (R),  Eric Swalwell (D),  Mike Thompson (D),  David Trone (D),  Ann Wagner (R),  Jackie Walorski (R), 

Referred to the House Committee on Ways and Means. (on 05/02/2019)

Official Document